Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| ULTRA LIGHT ADVANCED LOTION | ombrelle canada | Marketed | Feb 1, 2023 | Marketed |
| PRO-SITAGLIPTIN MALATE | PRO DOC LIMITEE | Marketed | Feb 1, 2023 | Marketed |
| PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | PRO DOC LIMITEE | Marketed | Feb 1, 2023 | Marketed |
| AG-QUETIAPINE FUMARATE | angita pharma inc. | Marketed | Jan 31, 2023 | Marketed |
| JAMP ATAZANAVIR | Jamp Pharma Corporation | Marketed | Jan 31, 2023 | Marketed |
| TRESIBA | Novo Nordisk Canada Inc | Marketed | Jan 30, 2023 | Marketed |
| BENVYON | Pfizer Canada Ulc | Marketed | Jan 30, 2023 | Marketed |
| JAMP ATOMOXETINE | Jamp Pharma Corporation | Marketed | Jan 30, 2023 | Marketed |
| JAMP ABIRATERONE | Jamp Pharma Corporation | Marketed | Jan 30, 2023 | Marketed |
| JAMP ATOMOXETINE | Jamp Pharma Corporation | Marketed | Jan 30, 2023 | Marketed |
| PEG 3350 | angita pharma inc. | Marketed | Jan 30, 2023 | Marketed |
| JAMP CEPHALEXIN | Jamp Pharma Corporation | Marketed | Jan 26, 2023 | Marketed |
| JAMP CEPHALEXIN | Jamp Pharma Corporation | Marketed | Jan 26, 2023 | Marketed |
| SITAGLIPTIN | sivem pharmaceuticals ulc | Marketed | Jan 26, 2023 | Marketed |
| JAMP ATAZANAVIR | Jamp Pharma Corporation | Marketed | Jan 26, 2023 | Marketed |
| JAMP ATAZANAVIR | Jamp Pharma Corporation | Marketed | Jan 26, 2023 | Marketed |
| SITAGLIPTIN | sivem pharmaceuticals ulc | Marketed | Jan 26, 2023 | Marketed |
| SITAGLIPTIN | sivem pharmaceuticals ulc | Marketed | Jan 26, 2023 | Marketed |
| ESSEPNA | fresenius kabi canada ltd | Marketed | Jan 25, 2023 | Marketed |
| ACID CONCENTRATE A1263 | chief medical supplies ltd | Marketed | Jan 23, 2023 | Marketed |
